Tarsus Pharmaceuticals Inc (TARS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 10M | 2.5M | 0 | 1.87M | 13.08M | 27.61M | 40.81M | 48.12M |
| Operating Income | -15.06M | -24.95M | -32.82M | -40.94M | -44.45M | -37.68M | -33.3M | -25.16M |
| Pre Tax Income | -13.6M | -23.42M | -31.42M | -39.15M | -41.9M | -35.73M | -33.29M | -23.42M |
| Net Income | -13.6M | -23.42M | -31.42M | -39.15M | -41.9M | -35.73M | -33.29M | -23.42M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -15.11M | -24.95M | -32.86M | -40.98M | -44.46M | -37.08M | -33.36M | -25.1M |
| EBITDA | -14.96M | -24.85M | -32.64M | -40.69M | -44.11M | -37.41M | -33.06M | -24.88M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 57.03M | 25.82M | 17.45M |
| Operating Income | -1.35M | -4.3M | -27M | -12.16M | -62.71M | -143.16M |
| Pre Tax Income | -1.32M | -4.67M | -26.81M | -13.77M | -62.1M | -135.89M |
| Net Income | -1.32M | -4.67M | -26.81M | -13.83M | -62.09M | -135.89M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.634 | -1.764 | -1.319 | -0.668 | -2.323 | -4.105 |
| EBIT | -1.35M | -4.55M | -27M | -12.23M | -62.63M | -143.26M |
| EBITDA | -1.35M | -4.26M | -26.9M | -11.85M | -62.39M | -142.28M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
